1. Animal and Plant Quarantine Agency. APQA Notice No. 2018-5: Regulations on Safety and Efficacy Evaluation for Veterinary Medicinal Products [Internet]. Animal and Plant Quarantine Agency;2018. [updated 2018 February 22; cited 2019 March 15]. Available from:. http://www.qia.go.kr/bbs/lawAnn/viewLawWebAction.do?id=152876&type=0.
2. Food and Drug Administration. Guidance for Industry No. 218: Cell-Based Products for Animal Use [Internet]. Center for Veterinary Medicine;2015. [updated 2015 June; cited 2019 March 15]. Available from:. https://www.fda.gov/downloads/AnimalVeterinary/GuidanceComplianceEnforcement/GuidanceforIndustry/UCM405679.pdf.
3. The Japanese Society for Animal Vaccine and Biomedical Research. 2014 Project Report for Development of Safety Testing of Regenerative Medicinal products for Animal Use: Draft Guideline on the Ensurement of Quality and Safety for Regenerative Medicinal Products (Allogeneic-derived) for Animal Use [Internet]. The Japanese Society for Animal Vaccine and Biomedical Research;2015. [updated 2015 March; cited 2019 March 15]. Available from:. http://www.jsavbr.jp/data/1432867667.pdf.
4. Animal and Plant Quarantine Agency. APQA Notice No. 2016-22: Guideline on Toxicity Testing for Veterinary Medicinal Products [Internet]. Animal and Plant Quarantine Agency;2016. [updated 2016 March 9; cited 2019 March 15]. Available from:. http://www.law.go.kr/LSW/admRulLsInfoP.do?admRulSeq=2100000042143.
5. Ministry of Food and Drug Safety. MFDS Guideline No. B1-2014-3-020. Guideline in Quality, Non-clinical and Clinical Assessment of Stem Cell Therapy Product [Internet]. Ministry of Food and Drug Safety;2014. [updated 2014 December; cited 2019 March 15]. Available from:. http%3A%2F%2Fwww.nifds.go.kr%2Fbrd%2Fm_158%2Fdown.do%3Fbrd_id%3D235%26seq%3D11723%26data_tp%3DA%26file_seq%3D1&usg=AOvVaw0L2fDSu9vg2J6ZnoOtfByd.
6. Animal and Plant Quarantine Agency. APQA Notice No. 2015-29: Guideline on Clinical Trial Management of Veterinary Medicinal Products [Internet]. Animal and Plant Quarantine Agency;2015. [updated 2015 October 20; cited 2019 March 15]. Available from:. https://www.qia.go.kr/guide/sitemap/bbs/lawAnn/viewLawWebAction.do?id=132510&type=0.
7. European Medicines Agency. EMA/CVMP/ADVENT/193811/2016: Stem Cell-Based Products for Veterinary Use: Specific Questions on Target Animal Safety to Be Addressed by ADVENT [Internet]. Committee for Medicinal Products for Veterinary Use;2016. [updated 2016 July 14; cited 2019 March 15]. Available from:. https://www.ema.europa.eu/en/stem-cell-based-products-veterinary-use-specific-questions-sterility-be-addressed-ad-hoc-expert.
8. The Veterinary International Cooperation on Harmonization. VICH GL43: Target Animal Safety for Veterinary Pharmaceutical Products [Internet]. The Veterinary International Cooperation on Harmonization Steering Committee;2008. [updated 2008 July; cited 2019 March 15]. Available from:. https://www.fda.gov/downloads/AnimalVeterinary/GuidanceComplianceEnforcement/GuidanceforIndustry/ucm052464.pdf.